Skip to content
Back to OMCL

Omnicell, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
11
Purchases
0
Sales
11
Purchase value
$0.00
Sale value
$3.03M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Nnamdi NjokuPresident & COO
4Rule 10b5-1 plan disclosed
Filed Nov 17, 2026Period of report Nov 15, 20260002034946-26-000015
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 16, 2026
Common StockF2F33,083$35.00$107.91K154,470.5647Direct
Filing footnotes · 3
  1. F1Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
  2. F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2026.
  3. F3The price reported in Column 4 is an exact price of $35.00 for all shares sold.
Open on SEC EDGAR
Nnamdi NjokuPresident & COO
4Rule 10b5-1 plan disclosed
Filed Aug 18, 2026Period of report Aug 15, 20260002034946-26-000013
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 17, 2026
Common StockF3F43,083$36.85$113.61K161,223.5647Direct
Filing footnotes · 4
  1. F1Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
  2. F2The balance is adjusted to reflect 882.1190 shares purchased under the Issuer's Employee Stock Purchase Plan on 8/15/26.
  3. F3This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2026.
  4. F4The price reported in Column 4 is an exact price of $36.85 for all shares sold.
Open on SEC EDGAR
Randall a LippsDirector · CHAIRMAN, CEO
4Rule 10b5-1 plan disclosed
Filed Jul 17, 2026Period of report Jul 15, 20260001227556-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 15, 2026
Common StockF1F2F310,000$47.00$470.00K345,861IndirectIn Trust with Wife
Filing footnotes · 4
  1. F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2026.
  2. F2The price reported in Column 4 is an exact price of $47.00 for all shares sold.
  3. F3Shares held in trust with Mr. Lipps' wife.
  4. F4Shares held in trust for the benefit of Mr. Lipps' children.
Open on SEC EDGAR
Nnamdi NjokuEVP, Chief Operating Officer
4Rule 10b5-1 plan disclosed
Filed May 19, 2026Period of report May 15, 20260002034946-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 18, 2026
Common StockF2F33,090$43.22$133.55K154,785.4457Direct
Filing footnotes · 3
  1. F1Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
  2. F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2026.
  3. F3The price reported in Column 4 is an exact price of $43.22 for all shares sold.
Open on SEC EDGAR
Corey J ManleyEVP&CHIEF LEGAL/ADMIN OFFICER
4Rule 10b5-1 plan disclosed
Filed May 19, 2026Period of report May 15, 20260001928727-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 18, 2026
Common StockF2F35,025$43.22$217.18K112,783.3392Direct
Filing footnotes · 3
  1. F1Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
  2. F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
  3. F3The price reported in Column 4 is an exact price of $43.22 for all shares sold.
Open on SEC EDGAR
Corey J ManleyEVP&CHIEF LEGAL/ADMIN OFFICER
4Rule 10b5-1 plan disclosed
Filed Mar 17, 2026Period of report Mar 15, 20260001928727-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common StockF3F47,405$34.69$256.88K96,717.3392Direct
Filing footnotes · 4
  1. F1Reflects performance-based restricted stock units that were previously granted on March 15, 2025, subject to the Company meeting certain stock performance objectives compared to the S&P 1000 Healthcare Index. On March 5, 2026 (the determination date), the Compensation Committee determined the performance criteria was met with respect to 22,445 performance-based restricted stock units (100% of target) of which 25% vested upon the one year anniversary of the grant date. The remaining performance-based restricted stock units will vest in equal quarterly increments once every three months over a three-year period (on each May 15, August 15, November 15, and February 15, respectively).
  2. F2Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
  3. F3This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
  4. F4The price reported in Column 4 is an exact price of $34.69 for all shares sold.
Open on SEC EDGAR
Corey J ManleyEVP&CHIEF LEGAL/ADMIN OFFICER
4Rule 10b5-1 plan disclosed
Filed Feb 18, 2026Period of report Feb 15, 20260001928727-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 17, 2026
Common StockF2F3F44,243$36.59$155.25K85,496.3392Direct
Filing footnotes · 4
  1. F1Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
  2. F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
  3. F3The price reported in Column 4 is an exact price of $36.59 for all shares sold.
  4. F4The balance is adjusted to reflect 87.3392 shares purchased under the Issuer's Employee Stock Purchase Plan on 2/15/26.
Open on SEC EDGAR
Corey J ManleyEVP&CHIEF LEGAL/ADMIN OFFICER
4Rule 10b5-1 plan disclosed
Filed Jan 12, 2026Period of report Jan 8, 20260001928727-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 8, 2026
Common StockF1F26,106$49.90$304.69K91,674Direct
Filing footnotes · 2
  1. F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
  2. F2The price reported in Column 4 is an exact price of $49.90 for all shares sold.
Open on SEC EDGAR
Corey J ManleyEVP&CHIEF LEGAL/ADMIN OFFICER
4
Filed Dec 17, 2025Period of report Dec 15, 20250001928727-25-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 16, 2025
Common StockF2F3278$43.30$12.04K97,780Direct
Filing footnotes · 3
  1. F1Reflects withholding of shares to cover taxes due in connection with the vesting of restricted stock units.
  2. F2This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
  3. F3The price reported in Column 4 is an exact price of $43.30 for all shares sold.
Open on SEC EDGAR
Corey J ManleyEVP&CHIEF LEGAL/ADMIN OFFICER
4Rule 10b5-1 plan disclosed
Filed Dec 5, 2025Period of report Dec 3, 20250001928727-25-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 3, 2025
Common StockF1F26,106$39.90$243.63K98,282Direct
Filing footnotes · 2
  1. F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2025.
  2. F2The price reported in Column 4 is an exact price of $39.90 for all shares sold.
Open on SEC EDGAR
Randall a LippsDirector · CHAIRMAN, PRESIDENT AND CEO
4Rule 10b5-1 plan disclosed
Filed Dec 3, 2025Period of report Dec 1, 20250001227556-25-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 1, 2025
Common StockF1F228,250$35.9679$1.02M386,648Direct
Filing footnotes · 5
  1. F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
  2. F2The price reported in Column 4 is a weighted average price of $35.9679. The sold price range between $35.65 to $36.4746. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3Shares held in trust with Mr. Lipps' wife.
  4. F4Shares held in trust for the benefit of Mr. Lipps' children.
  5. F5The options were granted on 2/4/2016 with 25% vested on the one-year anniversary of the grant date and the reaming amount vesting ratably over a 36 month period. The options were fully vested on 2/4/2020.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.